Effect of long-term tamoxifen exposure on genotoxic and epigenetic changes in rat liver: implications for tamoxifen-induced hepatocarcinogenesis

Carcinogenesis
Volodymyr TryndyakI P Pogribny

Abstract

Tamoxifen is a non-steroidal anti-estrogen used for the treatment of breast cancer and, more recently, as a chemopreventive agent in healthy women at high risk of developing breast cancer. On the other hand, tamoxifen is a potent hepatocarcinogen in rats, with both tumor-initiating and tumor-promoting properties. There is substantial evidence that hepatic tumors in rats are initiated as a result of formation of tamoxifen-DNA adducts; however, events subsequent to DNA adduct formation are not clear. Recently, it has been demonstrated that genotoxic carcinogens, in addition to exerting genotoxic effects, often cause epigenetic alterations. In the current study, we investigated whether or not the mechanism of tamoxifen-induced hepatocarcinogenesis includes both genotoxic and epigenetic components. Female Fisher 344 rats were fed a 420 p.p.m. tamoxifen diet for 6, 12, 18 or 24 weeks. Hepatic tamoxifen-DNA adduct levels, as assessed by high-performance liquid chromatography and electrospray tandem mass spectrometry, were 580 adducts/10(8) nt at 6 weeks, and increased to approximately 1700 adducts/10(8) nt by 18 weeks. Global liver DNA hypomethylation, as determined by an HpaII-based cytosine extension assay, was increased at all tim...Continue Reading

Citations

Sep 27, 2012·Cancer Letters·Igor P Pogribny, Frederick A Beland
Jan 16, 2008·Proceedings of the National Academy of Sciences of the United States of America·Carole YaukOlga Kovalchuk
Nov 1, 2011·Antioxidants & Redox Signaling·Igor KoturbashIgor P Pogribny
Jun 12, 2013·Carcinogenesis·Zdenko HercegChristopher P Wild
Jun 10, 2009·Mutagenesis·Karen Brown
Feb 19, 2008·Toxicological Sciences : an Official Journal of the Society of Toxicology·Mark R FieldenUNKNOWN Carcinogenicity Working Group
May 24, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Igor KoturbashIgor P Pogribny
Nov 21, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Neil A Youngson, Margaret J Morris
Dec 15, 2010·Environmental Health Perspectives·Igor KoturbashIvan Rusyn
Dec 1, 2009·Epigenomics·Igor P Pogribny
Nov 15, 2014·Archives of Toxicology·Paul JenningsJeffrey S Wiseman
Mar 9, 2007·Mutation Research·Igor P PogribnyOlga Kovalchuk
Jun 15, 2007·Trends in Genetics : TIG·Mario F Fraga, Manel Esteller
Aug 16, 2014·Toxicology·Aline de ContiIgor P Pogribny
Jul 30, 2017·Environmental and Molecular Mutagenesis·Todd A TownsendMugimane G Manjanatha
Apr 27, 2007·Annals of the New York Academy of Sciences·Mario F FragaManel Esteller
Jan 23, 2014·Environmental and Molecular Mutagenesis·Kelly M Bakulski, M Daniele Fallin
Jan 18, 2020·Environmental Health Perspectives·Felicia Fei-Lei Chung, Zdenko Herceg
Apr 12, 2011·International Journal of Cancer. Journal International Du Cancer·Carlos Eduardo Andrade ChagasFernando Salvador Moreno
Oct 22, 2019·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Nicholas BirkettDaniel Krewski
Nov 19, 2013·International Journal of Cancer. Journal International Du Cancer·Grace ChappellIgor P Pogribny
Jul 27, 2018·Toxicology and Applied Pharmacology·John RooneyJ Christopher Corton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.